US 9670549
Gene expression signatures of neoplasm responsiveness to therapy
granted A61KA61K31/4045A61K31/439
Quick answer
US patent 9670549 (Gene expression signatures of neoplasm responsiveness to therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/4045, A61K31/439